Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).
Galiè
Nazzareno
N
Institute of Cardiology, Bologna University Hospital, Via Massarenti, 9, 40138 Bologna, Italy. nazzareno.galie@unibo.it
Hoeper
Marius M
MM
Humbert
Marc
M
Torbicki
Adam
A
Vachiery
Jean-Luc
JL
Barbera
Joan Albert
JA
Beghetti
Maurice
M
Corris
Paul
P
Gaine
Sean
S
Gibbs
J Simon
JS
Gomez-Sanchez
Miguel Angel
MA
Jondeau
Guillaume
G
Klepetko
Walter
W
Opitz
Christian
C
Peacock
Andrew
A
Rubin
Lewis
L
Zellweger
Michael
M
Simonneau
Gerald
G
D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003935:Diagnostic Techniques, Cardiovascular; D017079:Exercise Tolerance / Q000502:physiology; D006331:Heart Diseases / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D000860:Hypoxia / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D016040:Lung Transplantation; D011379:Prognosis; D011668:Pulmonary Veno-Occlusive Disease / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D012017:Referral and Consultation; D012307:Risk Factors; D013727:Terminal Care / Q000379:methods; D013923:Thromboembolism / Q000150:complications / Q000175:diagnosis / Q000628:therapy
D015415:Biomarkers; D002317:Cardiovascular Agents